Loading

SOCIETY

  • by Paul Armentano, NORML Deputy Director December 1, 2017

    personal_cultivationSales of alcoholic beverages decline following the enactment of medical marijuana access laws, according to a working paper authored by a team of researchers from the University of Connecticut and Georgia State University.

    Authors evaluated the relationship between medical marijuana laws and retail alcohol sales for more than 2,000 US counties for the years 2006 to 2015. Alcohol sales trends in medical cannabis states were compared to sales trends in states where cannabis remained illegal. Researchers determined that counties located in medical cannabis states, on average, experienced a reduction in monthly alcohol sales of 15 percent.

    Researchers concluded: “We find that marijuana and alcohol are strong substitutes. … States legalizing medical marijuana use experience significant decreases in the aggregate sale of alcohol, beer and wine. Moreover, the effects are not short-lived, with significant reductions observed up to 24 months after the passage of the law.”

    Consumer trend data from California reports that those with legal access to cannabis frequently reduce their alcohol intake. A 2016 analysis of beer sales in Colorado, Oregon, and Washington reported that retail sales “collectively underperformed” in the years following the enactment of adult use marijuana regulation.

    Full text of the study, “Helping settle the marijuana and alcohol debate: Evidence from scanner data,” appears online here.

  • by NORML November 28, 2017

    revolutionbumper#GivingTuesday is a day that unites us in generosity and celebration for all that we have accomplished. After the two most busiest shopping days of the year, #GivingTuesday gives us all a chance to give back. This year we’re going BIG, and the only way we can ensure that happens is with your help.

    The holiday season is in full swing, and naturally we are forced to think about all we are thankful for. We at NORML could not be more grateful for YOU and all of your continuous, unconditional support as we work for our shared vision of a legalized nation.

    During this joyous time of giving thanks, one of our generous supporters offered to match the first $5,000 in donations for #GivingTuesday.

    Double your impact and make a donation to propel us to the finish line and end marijuana prohibition.

    We’ve made so much progress over the last year, all thanks to you. But there is still so much to be done. We expect 2018 to be even more successful for the movement, and we need you to help continue our momentum by making a contribution in honor of #GivingTuesday. Now more than ever is when we need your support to ensure that we achieve a fair legalization and equitable marijuana market.

    Donate today to have your contribution matched dollar for dollar!

    Every act of generosity counts, and each means even more when we give together. Join NORML’s global giving movement where millions of people have come together to support and champion our cause of ending marijuana prohibition. Become one of those people today, on #GivingTuesday.

    Many thanks,
    The NORML Team

    P.S. Shopping on Amazon for holiday gifts or just day to day expenses? Through the Amazon-smile program, you can have a portion of your costs be donated to NORML and our reform efforts.  

  • by NORML November 27, 2017

    revolutionbumperOne of NORML’s primary missions is to move public opinion sufficiently to legalize the responsible use of marijuana by adults. One of the ways we successfully achieve this goal is by debunking marijuana myths and half-truths via the publication of timely op-eds in online and print media. Since the mainstream media seldom casts a critical eye toward many of the more over-the-top claims about cannabis, we take it upon ourselves to set the record straight.

    The majority of NORML’s rebuttals are penned by Deputy Director Paul Armentano. In the past few weeks, he has published numerous op-eds highlighting the therapeutic effects of marijuana, the racial disparities in prohibitions’ enforcement, and the overall need for reform.

    Below are links to a sampling of his recent columns:

    “Cannabis has a record of safety, efficacy”
    Pittsburgh Tribune-Review. November 23, 2017

    “African Americans are disproportionately arrested for low-level marijuana violations — and the disparity is growing”
    Alternet. November 21, 2017.

    “Cannabis saves lives”
    Santa Fe New Mexican. November 13, 2017

    “Medical marijuana should be legal in Indiana”
    Indianapolis Star. November 10, 2017

    “How to heal our sick system for managing pain and fighting the opioid epidemic”
    Los Angeles Times. November 3, 2017.

    “American opinions have changed when it comes to marijuana, federal law should change too”
    The Hill. October 28, 2017

    For a broader sampling of NORML-centric columns and media hits, please visit NORML’s ‘In the Media’ archive here.

    If you see the importance of NORML’s educational and media outreach efforts, please feel free to show your support by making a contribution here.

  • by Paul Armentano, NORML Deputy Director November 20, 2017

    Pain reliefChronic pain patients enrolled in a statewide medical cannabis access program are significantly more likely to either reduce or cease their use of opioids as compared to non-enrolled patients suffering from similar pain conditions, according to data published online in the journal PLOS One.

    A team of investigators at the University of New Mexico assessed opioid prescription use patterns over a 21-month period in 37 pain patients enrolled in the state’s medicinal cannabis program versus 29 non-enrolled patients.

    Compared to non-users, medical cannabis enrollees “were more likely either to reduce daily opioid prescription dosages between the beginning and end of the sample period (83.8 percent versus 44.8 percent) or to cease filling opioid prescriptions altogether (40.5 percent versus 3.4 percent).” Enrollees were also more likely to report an improved quality of life.

    Authors concluded, “The clinically and statistically significant evidence of an association between MCP enrollment and opioid prescription cessation and reductions and improved quality of life warrants further investigations on cannabis as a potential alternative to prescription opioids for treating chronic pain.”

    Prior studies similarly report that patients enrolled in cannabis access programs are more likely to reduce their use of opioids and other prescription drugs.

    Full text of the study, “Association between medical cannabis and prescription opioid use in chronic pain patients: A preliminary cohort study,” appears online here. NORML’s marijuana and opioids fact-sheet is online here.

  • by Paul Armentano, NORML Deputy Director November 16, 2017

    voteThe Connecticut state chapter of NORML and the Yale University branch of the group Students for Sensible Drug Policy will co-host the inaugural gubernatorial candidate debate of the 2018 governor’s race. Candidates will be asked to weigh in on questions specific to adult use marijuana legalization, criminal justice reform, hemp production, and the state’s current medical marijuana program, among other issues.

    Confirmed to appear at the event are: Middletown Mayor Dan Drew (D), former state Sen. Jonathan Harris (D) of West Hartford and Afghanistan war veteran Micah Welintukonis (R). Organizers are actively reaching out to additional candidates.

    The debate is scheduled for Tuesday November 28, 2017, from 7:00pm to 8:30pm at Yale University’s Sheffield Sterling Strathcona, Room 114 at 1 Prospect Street in New Haven. The debate will be moderated Aaron J. Romano, legal advisor for Connecticut NORML and a member of NORML’s Legal Committee. The event will be live-streamed on the Connecticut NORML facebook page here.

    Several legislative proposals to regulate the adult use and sale of cannabis in Connecticut were debated during the spring 2017 session. However, momentum for these efforts stalled after Democrat Gov. Dan Malloy publicly expressed his opposition to legalizing cannabis.

    According to statewide polling, 63 percent of registered voters favor permitting adults to legally possess personal use quantities of cannabis. When considering new sources of tax revenue in Connecticut, 70 percent of voters support the idea of “legalizing and taxing marijuana.”

Page 1 of 15512345...102030...Last »